Best Life Sciences Companies in Warsaw, Poland
The 43 best Life Sciences companies in Warsaw, Poland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Quantum.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Warsaw
| # | Company | Last round | Disclosed funding | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Airway Medix Developer of medical devices for ventilated patients in intensive care units | — | — | — | Marek Orlowski Founder | Public | 110 patents Advanced airway and respiratory catheter devices with dynamic tip occlusion and dual-balloon ventilation. | — |
| 2 | Biotech Varsovia Dietary supplements for women's health | — | — | — | Wojciech Sliwka CEO and Founder | Funding Raised | — | — |
| 3 | BioVectis Provider of molecular biology tools | — | — | — | Krzysztof Kucharczyk CEO | Unfunded | — | — |
| 4 | Cambridge Chocolate Technologies Manufacturer of nutritional chocolates | — | — | 4,125 | Anna Aranowska Bablok CEO & President | Funding Raised | — | — |
| 5 | Clinscience Provider of clinical trial management suite for research and development | — | — | 184 | Tomasz Dabrowski CEO | Unfunded | — | — |
| 6 | CTL Laser-based technologies for dermal application | — | — | 102 | — | Unfunded | — | — |
| 7 | Curiosity Diagnostics Point-of-care analyzer for molecular diagnostics | — | — | — | Piotr Garstecki CEO | Deadpooled | 64 patents Microfluidic chips and particle reagents for automated nucleic‑acid sample preparation and thermal cycling | — |
| 8 | Helix Immuno-Oncology Developing tumour targeting antibody drug conjugates | — | — | 4 | — | Funding Raised | 2 patents Patents concentrated in its core technology | — |
Top 12 Life Sciences companies in Warsaw
#1
Seed · Warsaw, Masovian Voivodeship · founded 2023$9.8Mraised▾
Provider of AI-powered clinical trial simulation. It offers a generative AI co-pilot for clinical development, enabling accurate simulation of clinical trials using digital twins. The platform integrates various biological and medical data modalities to understand human biology at multiple scales, from molecular to population levels. This allows for granular prediction of clinical endpoint values and adverse events, providing insights into factors driving predictions. The model is designed to accelerate drug development and optimize research and development investments.
- Apr 2025Seed$9.8M
#2
Series A · Warsaw, Masovian Voivodeship · founded 2018$10.2Mraised▾
Developer of quantum devices for cardiac surgery, cardiology, and respiratory medicine. It offers Heart Sense a probe to significantly increase safety during cardiac surgery and Heart Guard technology is a system for continual measurement of cardiac metabolism.
- Jun 2024Series A$10.2M
#3
Public · Warsaw, Masovian Voivodeship · founded 2012$2.9Mraised▾
Developer of small molecule drugs to treat cancer and inflammatory diseases. It has small molecule mRNA targeting discovery platform that modulates protein and RNA targets to treat cancer, fibrotic and inflammatory diseases.
- May 2024Grant (prize money)$241.1K
- Apr 2019Grant (prize money)$237.2K
- Feb 2018Grant (prize money)$1.7M
- Mar 2017Series A—
#4
Series A · Warsaw, Masovian Voivodeship · founded 2018 · 38 employees$9Mraised▾
Provider of IoT-enabled device for baby monitoring. The telemedical device for parents enables remote monitoring of children at home. The device can be used for throat image, ear, skin examination, temperature measurement and also acts like a stethoscope. The device is used for examining before visiting the doctor for consultation. The doctor uses the results via the app for remote health assessment and interpretation using algorithms.
- Dec 2021Series A$5.6M
#5
Funding Raised · Warsaw, Masovian Voivodeship · founded 2008 · 10 employees$6.6Mraised▾
Neuro Device Group has developed a portfolio of neurostimulation devices. The product developed is called Neuro device VOIC (rehabilitation of aphasia by neuromodulation and electrical stimulation of the brain), nuroStym tES (non-invasive stimulation of central nervous system for neurological, psychiatric, and developmental disorders), eVNS (VGuard) -(noninvasive transcutaneous Vagus Nerve Stimulation for treatment of Alzheimer disease). The other products developed are Neuro Device CAMRI(recording camera in MRI scanners), Neuro Device SCENT(measuring reactions of neuronal system to scents) and Neuro Device TACTI (preoperative fMRI diagnostics)
- Jul 2019Grant (prize money)$55.7K
- Feb 2019Grant (prize money)$57.3K
- 2018Grant (prize money)$20K
- Sep 2016Grant (prize money)$210.2K
#6
Series A · Warsaw, Masovian Voivodeship · founded 2019$4Mraised▾
Developer of CAR-T cell therapies to treat cancer. The company uses proprietary CAR-T technology based on genetically modified T lymphocytes a chimeric antigen receptor -T for the treatment of blood cancers.
- Feb 2022Series A$4M
#7
Seed · Warsaw, Masovian Voivodeship · founded 2016 · 26 employees$4.6Mraised▾
Provider of AI-based software research for molecule drug designing and synthesis. The technology enables users to pick search criteria and proposes relevant reactions, scores them, and assembles them into full synthesis pathways for molecule synthesis.
- May 2021Seed$4.6M
- Aug 2019Seed—
#8
Seed · Warsaw, Masovian Voivodeship · founded 2020 · 11 employees$1.5Mraised▾
Developer of AI-based vaccine discovery solutions for drug development. It offers an AI platform that analyses genomes of SARS-CoV-2, indicates future variants, and finds sequences for drugs and vaccines.
- Jul 2022Seed$1.5M
- Jul 2022Grant (prize money)—
#9
Funding Raised · Warsaw, Masovian Voivodeship · founded 2019 · 17 employees$813.6Kraised▾
Developer of mRNA therapeutics to treat cancer and other diseases. The company develops mRNA-based drugs to deliver a defined generic message into the cells to produce any kind of protein for cancer treatments.
- Dec 2022Grant (prize money)$813.6K
#10
Public · Warsaw, Masovian Voivodeship · founded 2002 · 106 employees$6.3Mraised▾
Polski Bank Komórek Macierzystych (Polish Stem Cell Bank) is the largest stem cell bank of Poland. It has over 1,30,000 clients. It has also received the consent from the Main Pharmaceutical Inspector (GIF) for the production of an advanced therapy medicinal product of mesenchymal cells from Wharton's Jelly. The manufactured drug product is administered to patients undergoing experimental medical treatments if the existing standard therapy did not achieve the expected results. The most common cells prepared by PBKM were administered in neurological (mainly in autism, cerebral palsy, amyotrophic lateral sclerosis), haematological and orthopaedic diseases.
- Nov 2009PE$6.3M
#11
Seed · Warsaw, Masovian Voivodeship · founded 2022 · 18 employees$250Kraised▾
Developer of a centralized repository platform for medical research. It offers a blockchain-based medical data donation system that provide data to hospitals, clinics, scientific research, and medical studies.
- Dec 2022Seed$250K
#12
Early Stage · Warsaw, Masovian Voivodeship · founded 1993$568.9Kraised▾
Portfolio of IV infusion sets
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Warsaw is moving
A read on the academic research around Biotechnology in Warsaw — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 71 papers.
- Warsaw University of Life Sciences30
- University of Warsaw20
- Medical University of Warsaw16
- Warsaw University of Technology5
- Cardinal Stefan Wyszynski University in Warsaw4
- Messenger RNA2
- Plasmid2
- DNA sequencing2
- In vitro2
- Gene2
- Health benefits3
- Gene2
- Competitive exclusion2
- Probiotic2
- Pathogen2
- Antibiotic resistance3
- Narrative review2
- Phenotype1
- Livestock1
- Antibiotics1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.